CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
LONDON--(BUSINESS WIRE)--Please replace the release with the following corrected version. The updated release reads: FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS...
First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
LONDON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the results from the RHEIA Trial, a first-of-its-kind trial focused exclusively on outcomes for women receiving transcathete...
Levi & Korsinsky Announces an Investigation on Behalf of Edwards Lifesciences Corporation (EW) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) conce...
East West Petroleum Shareholders Approve Return of Capital
Vancouver, British Columbia--(Newsfile Corp. - August 16, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that its shareholders have today approved its previou...
Should You Hold Edward Lifesciences (EW) in Your Portfolio Now?
Edward Lifesciences' (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.
Investors who lost money on Edwards Lifesciences Corporation should contact Levi & Korsinsky about an ongoing investigation - EW
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concer...
Edwards Lifesciences (EW) Reliance on International Sales: What Investors Need to Know
Evaluate Edwards Lifesciences' (EW) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Edwards Lifesciences cut TAVR guidance, stock price dropped by over 31%. Recent acquisitions and divestiture of the Critical Care business show strategic focus on the structural heart market. Analy...
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concern...
Edwards Lifesciences Stock Plummeted Today. Here's Why
Edwards Lifesciences (EW) shares swooned Thursday, dropping after the company damped expectations for heart valve replacement sales growth on Wednesday.
Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metr...
East West Petroleum Announces Proposed Return of Capital
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in ...
Here's Why You Should Retain Edward Lifesciences (EW) for Now
Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.
Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year?
Here is how Edwards Lifesciences (EW) and SNDL Inc. (SNDL) have performed compared to their sector so far this year.
Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends
Explore how Edwards Lifesciences' (EW) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Related Companies